annb0t
Top 20
Celularity, Inc.
Commercial Biomaterials Business, Degenerative Disease Programs Continue to Gather Momentum
Animal and Preclinical Data Support Significant Opportunities in Osteoarthritis for Biomaterial-Cell Therapy Combination Approach
FLORHAM PARK, N.J., Jan. 26, 2023 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (âCelularity,â the âCompanyâ), a U.S.-based biotechnology company developing placental-derived allogenic cell therapies and biomaterial-based regenerativ...
>>> Read more: Celularity Completes Strategic Review of 2023 Initiatives, Including Anticipated Biomaterials Production Ramp-Up and Pipeline Prioritization of Next-Generation Product Candidates
Commercial Biomaterials Business, Degenerative Disease Programs Continue to Gather Momentum
Animal and Preclinical Data Support Significant Opportunities in Osteoarthritis for Biomaterial-Cell Therapy Combination Approach
FLORHAM PARK, N.J., Jan. 26, 2023 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (âCelularity,â the âCompanyâ), a U.S.-based biotechnology company developing placental-derived allogenic cell therapies and biomaterial-based regenerativ...
>>> Read more: Celularity Completes Strategic Review of 2023 Initiatives, Including Anticipated Biomaterials Production Ramp-Up and Pipeline Prioritization of Next-Generation Product Candidates
